Polysaccharide immunomodulators as therapeutic agents: Structural aspects and biologic function

Clinical Microbiology Reviews

Volumn 13, Issue 4, 2000, Pages 523-533

  Tzianabos, A O ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOLYTE; BACTERIAL POLYSACCHARIDE; BETA 1,3 GLUCAN; CELL ADHESION MOLECULE; CYTOKINE; HYALURONIC ACID; IMMUNOMODULATING AGENT; KRESTIN; MANNAN; PEPTIDOGLYCAN P; POLYSACCHARIDE A; UNCLASSIFIED DRUG;

ABDOMINAL ABSCESS; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BACTERIAL MEMBRANE; BACTEROIDES FRAGILIS; CANCER; CANDIDA ALBICANS; CELL INTERACTION; CELLULAR IMMUNITY; CLINICAL TRIAL; CRYPTOCOCCUS NEOFORMANS; CYTOKINE RELEASE; HOST; HUMAN; IMMUNOMODULATION; MACROPHAGE; MONOCYTE; MUSHROOM; NEUTROPHIL; NONHUMAN; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; CARBOHYDRATE SEQUENCE; HUMAN; INFECTION; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; RATS;

EID: 0033783189     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.13.4.523-533.2000     Document Type: Review

References (80)

1. PGG-glucan activates NF-kappaB-like and NF-IL-6-like transcription factor complexes in a murine monocytic cell line
2. Mechanisms of phagocytosis in macrophages
3. Sequential production of IL-2, IFN-gamma and IL-10 by individual staphylococcal enterotoxin B-activated T helper lymphocytes
4. A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients
5. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients
6. Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using resolution NMR spectroscopy
7. Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen-presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival
8. Betafectin PGG-glucan: A novel carbohydrate immunomodulator with anti-infective properties
9. Beneficial effect of enhanced macrophage function in the trauma patient
10. Synergistic effect of nonspecific immunostimulation and antibiotics in experimental peritonitis
11. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: Differential stimulatory effect on mouse and rat lymphocytes in vitro
12. Glucan-activated macrophages: Functional characteristics and surface morphology
13. Functions of hyaluronan in wound repair
14. Passive transfer of poly-(1-6)-β-glucotriosyl-(1-3)-β-glucopyranose glucan protection against lethal infection in an animal model of intra-abdominal sepsis
15. The effect of molecular weight and beta-1,6-linkages on priming of macrophage function in mice by (1,3)-beta-D-glucan
16. Generation of leukotrienes by human monocytes upon stimulation of their beta-glucan receptor during phagocytosis
17. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor
18. Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations Betafectin Gastrointestinal Study Group
19. Therapeutic effect of yeast glucan in mice infected with Mycobacterium leprae
20. Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice
21. Effect of soluble aminated beta-1,3-D-polyglucose on human monocytes: Stimulation of cytokine and prostaglandin E2 production but not antigen-presenting function
22. Translational control: A general mechanism for gene regulation during T cell activation
23. Characterization of Candida albicans mannan-induced, mannan-specific delayed-hypersensitivity suppressor cells
24. Intravenous injection of Candida-derived mannan results in elevated tumor necrosis factor alpha levels in serum
25. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis
26. Therapeutic effects of nitric oxide inhibition during experimental fecal peritonitis: Role of interleukin-10 and monocyte chemoattractant protein 1
27. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis
28. The role of neutrophils as cytotoxic cells in lung metastasis: Suppression of tumor cell metastasis by a biological response modifier (PSK)
29. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis
30. Prophylactic anti-infective activity of poly-[1-6]-beta-D-glucopyranosyl-[1-31-beta-D-glucopryanose glucan in a guinea pig model of staphylococcal wound infection
31. Immunomodulatory functions of low-molecular weight hyaluronate in an acute rat renal allograft rejection model
32. Cytokines and PGE2 modulate the phagocytic function of the beta-glucan receptor in macrophages
33. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo
34. The effect of glucan - A host resistance activator - And ampicillin on experimental intraabdominal sepsis
35. Glucan-induced enhancement of host resistance in experimental intraabdomirtal sepsis
36. Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity
37. Anergic T cells as suppressor cells in vitro
38. Direct action of a protein-bound polysaccharide, PSK, on transforming growth factor-beta
39. The application of various protic acids in the extraction of (1→3)-beta-D-glucan from Saccharomyces cerevisiae
40. Receptor binding and internalization of a water-soluble (1-3)-13-glucan biologic response modifier in two monocyte/macrophage cell lines
41. Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor
42. A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae)
43. Anti-infective effect of poly β1-6 glucotriosyl-β1-3-glucopyranose glucan in vivo
44. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: Comparison of the pathogenic potential of encapsulated and unencapsulated strains
45. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model
46. Experimental intra-abdominal abscesses in rats: Quantitative bacteriology of infected animals
47. Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis
48. Modulation of murine hemopoiesis by glucan
49. Identification of a reticuloendothelial stimulating agent in zymosan
50. Specificity of membrane complement receptor type three (CR3) for beta-glucans
51. Persistence of peptide-induced CD4+ T cell anergy in vitro
52. Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes
53. Cellular control of abscess formation: Role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis
54. Celluar immunity to Bacteroides fragilis capsular polysaccharide
55. Activation and interaction of CD44 and hyaluronan in immunological systems
56. Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan
57. Reduction of infection-stimulated periapical bone resorption by the biological response modifier PGG glucan
58. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense
59. Novel and established applications of microbial polysaccharides
60. CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
61. Prophylaxis with the immunomodulator PGG glucan enhances antibiotic efficacy in rats infected with antibiotic-resistant bacteria
62. Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators
63. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis
64. Structural features of polysaccharides that induce intra-abdominal abscesses
65. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation
66. The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides
67. IL-2 mediates protection against abscess formation in an experimental model of sepsis
68. C-type lectins and galectins mediate innate and adaptive immune functions: Their roles in the complement activation pathway
69. PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: Evidence for a glycosphingolipid beta-(1,3)-glucan receptor
70. Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan
71. Effects of Coriolus versicolor polysaccharides on superoxide dismutase activities in mice
72. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer
73. Immunotherapeutic modification of Escherichia coli-induced experimental peritonitis and bacteremia by glucan
74. Glucan immunomodulation in experimental E. coli sepsis
75. Glucan induced modification of experimental Staphylococcus aureus infection in normal, leukemic and immunosuppressed mice
76. Development of a water-soluble, sulfated (1→3)-beta-D-glucan biological response modifier derived from Saccharomyces cerevisiae
77. Effect of glucan on neutrophil dynamics and immune function in Escherichia coli peritonitis
78. Beta-glucan, a 'specific' biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18)
79. A new method for the quantification of beta-glucan in plasma and its application in the diagnosis of postoperative infection
80. MCP-1 protects mice in lethal endotoxemia